Leisha Emens, MD, PhD
Disclosures: Receipt of Intellectual Property Rights/Patent Holder-Aduro Biotech-Principal_Investigator-The breast cancer vaccine I developed and the IND was licensed to Aduro Biotech.,Consulting Fee-Syndax-Other_Role-DSMB member,Consulting Fee-Gritstone-Other_Role-advisory board,Consulting Fee-Peregrine -Other_Role-advisory board,Consulting Fee-Bayer Corporation-Other_Role-Scientific Advisory Board,Royalty-Molecuvax-Other_Role-Scientific Advisory Board,Consulting Fee-eTheRNA-Other_Role-Scientific Advisory Board,Contracted Research-EMD Serono-Principal_Investigator,Contracted Research-Genentech, Inc.-Principal_Investigator Other_Role-Chair, Steering Committee, advisory board,Contracted Research-Roche-Principal_Investigator Other_Role-Chair, Steering Committee, advisory board,Contracted Research-AstraZeneca-Principal_Investigator,Contracted Research-Maxcyte-Principal_Investigator,Consulting Fee-AstraZeneca-Other_Role-Advisory Board member,Contracted Research-Aduro Biotech-Principal_Investigator,Consulting Fee-Amgen-Other_Role-advisory board member,Consulting Fee-Celgene-Other_Role-Advisory Board member,Consulting Fee-Vaccinex-Other_Role-Advisory Board member,Consulting Fee-Amgen-Other_Role-Advisory Board member,Consulting Fee-Syndax-Other_Role-Advisory Board member,Contracted Research-Corvus-Principal_Investigator,Consulting Fee-Abbvie-Other_Role-advisory board member,Consulting Fee-Medimmune-Other_Role-advisory board member,Consulting Fee-Bristol-Myers Squibb-Principal_Investigator Other_Role-Advisory Board,Consulting Fee-Replimune-Other_Role-Advisory Board,Consulting Fee-Macrogenics-Other_Role-Advisory Board
No Bio Available.